LSE •
Healthcare •
Biotechnology •
Quote as of 10/30/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization4.89 mln
Float381 mln
Earnings Date05/05/2027
Piotroski F-Score
2
/ 9
Weak
Relative Strength
98
/ 100
Top performer
ROE
193
Extraordinary
ROA
-282
Deeply negative
Business Description
Cizzle Biotechnology Holdings Plc is a UK-based company focused on detecting cancer at an early stage. Its primary work centers on a simple blood test designed to identify lung cancer early, using a protein marker called CIZ1B. The company operates out of London.